Bnp Paribas Asset Management Holding S.A. Arbutus Biopharma Corp Transaction History
Bnp Paribas Asset Management Holding S.A.
- $41 Billion
- Q2 2025
A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Arbutus Biopharma Corp stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 1,756 shares of ABUS stock, worth $7,954. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,756Holding current value
$7,954% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ABUS
# of Institutions
183Shares Held
118MCall Options Held
1MPut Options Held
478K-
Morgan Stanley New York, NY24.2MShares$109 Million0.01% of portfolio
-
Whitefort Capital Management, LP New York, NY13.3MShares$60.4 Million14.31% of portfolio
-
Black Rock Inc. New York, NY11.6MShares$52.3 Million0.0% of portfolio
-
Two Seas Capital LP Rye, NY10.4MShares$47.3 Million0.6% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.09MShares$41.2 Million0.0% of portfolio
About Arbutus Biopharma Corp
- Ticker ABUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 149,951,008
- Market Cap $679M
- Description
- Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...